<DOC>
	<DOC>NCT00843388</DOC>
	<brief_summary>A double blind, randomized, cross over study in type 1 diabetic patients. 20 patients, age 18-65 years is treated with spironolacton (Hexalacton (R)) for 60 days followed by 60 days treatment with placebo(or opposite). Primary aim: albuminuria, an expected decrease during hexalacton treatment. Secondary aim: ambulatory blood pressure, GFR, plasma-renin, angiotensin, aldosteron.</brief_summary>
	<brief_title>A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>type 1 diabetes age 1880 years microalbuminuria blood pressure&gt; 160/100 mmHg persistent macroalbuminuria pregnancy or in risc of this PPotassium&gt;5.7 mmol/l Eplerone treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>